HIF1A and metastatic neoplasm: There was elevated expression of all the three genes was observed in metastatic group compared to patients with non-metastatic disease as there was 85%, 62% and 52% of patients in the metastatic group were exhibiting high expression of HIF-1α, MDR1 and LAPTM4B, respectively.